Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[BCG in reflux].

A Böhle1, J Schüller, A Knipper

  • 1Klinik für Urologie, Medizinischen Universität zu Lübeck.

Der Urologe. Ausg. A
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Intravesical bacillus Calmette-Guérin (BCG) immunotherapy is safe for patients with vesicorenal reflux undergoing treatment for superficial bladder carcinoma. This approach does not increase complications and may be beneficial for managing multifocal tumors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Type 1 Diabetes Mellitus in the First Years of Life - Onset, Initial Treatment, and Early Disease Course.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2024
Same author

[Intravesical gene therapy for patients with BCG-refractory NMIBC?]

Der Urologe. Ausg. A·2021
Same author

The association between anti-inflammatory effects of long-term lithium treatment and illness course in Bipolar Disorder.

Journal of affective disorders·2020
Same author

[Suture-free amniotic membrane transplantation].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2013
Same author

Fundamental Studies of Fiber-Guided Soft Tissue Cutting by Means of Pulsed Midinfrared Lasers and their Application in Ureterotomy.

Journal of biomedical optics·2012
Same author

[Secondary malignancies in urinary diversions].

Der Urologe. Ausg. A·2012

Area of Science:

  • Urology
  • Oncology
  • Immunology

Context:

  • Superficial bladder carcinoma recurrence is common.
  • Vesicorenal reflux presents a challenge for intravesical therapies.
  • Bacillus Calmette-Guérin (BCG) is a standard intravesical immunotherapy.

Purpose:

  • To evaluate the safety and tolerability of intravesical BCG in patients with vesicorenal reflux.
  • To compare complication rates in patients with and without reflux receiving BCG therapy.

Summary:

  • Nine patients with vesicorenal reflux received intravesical BCG for superficial bladder carcinoma.
  • One patient experienced fever, possibly due to stent obstruction; others tolerated treatment well.
  • No significant increase in toxicity was observed compared to a control group without reflux.

Related Experiment Videos

Impact:

  • Intravesical BCG can be safely administered to patients with vesicorenal reflux.
  • This treatment may be particularly desirable for managing multifocal urothelial carcinoma in this subgroup.
  • The findings support the use of BCG immunotherapy in reflux patients, potentially improving outcomes.